1. Drug Resistant Epilepsy - K.Vita
  2. K.Vita clinical trial summary: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy | Evidence Summary

K.Vita clinical trial summary: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy | Evidence Summary

Want to access this resource?

REGISTER NOW

OR LOGIN IF YOU ARE ALREADY REGISTERED

DESCRIPTION

A visual summary of the K.Vita feasibility study published in 2021 in Brain Communications journal. An overview of how K.Vita was implemented and evaluated for acceptability, tolerability and compliance with dietary intervention.

 

Download the clinical research paper to read the full study.

DOWNLOAD

Author

  • Vitaflo Dietitians

Published

  • 01/12/2021

TAGS

Drug Resistant Epilepsy - K.Vita

OTHER RESOURCES YOU MAY BE INTERESTED IN

Events
K.Vita – From Laboratory To Clinical Use, Including Case Studies of Use In Glut 1 Deficiency Syndrome | Event Recording
Events
K.Vita in an Unknown Epilepsy Syndrome | Event Recording
Events
Using K.Vita in Tuberous Sclerosis Complex | Event Recording
Events
Using K.Vita With a Tube-fed Patient With Drug Resistant Epilepsy | Event Recording

WE HAVE A WEALTH OF RESOURCES FOR

PKU - Infants

PKU - Children

PKU - Adolescents and Adults

Maternal PKU

PKU & GMP

Rare disorders of protein metabolism

Lipid Disorders

Glycogen Storage Disease

Drug Resistant Epilepsy - Ketogenic Diet

Drug Resistant Epilepsy - K.Vita

Paediatric Kidney Disease

Nutrition Support